Gennex Laboratories Limited (GENNEX.BO)
INR 13.96
(5.84%)
INR 13.96
(5.84%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.29 Billion INR | 73.82% |
| 2022 | 1.32 Billion INR | 94.51% |
| 2021 | 680.26 Million INR | 15.49% |
| 2020 | 589.01 Million INR | 3.44% |
| 2019 | 569.43 Million INR | 10.08% |
| 2018 | 517.3 Million INR | 2.51% |
| 2017 | 504.65 Million INR | 2.55% |
| 2016 | 492.11 Million INR | 17.77% |
| 2015 | 417.86 Million INR | 6.59% |
| 2014 | 392.04 Million INR | -0.97% |
| 2013 | 395.89 Million INR | 8.92% |
| 2012 | 363.47 Million INR | 5.74% |
| 2011 | 343.76 Million INR | 21.65% |
| 2010 | 282.59 Million INR | -1.4% |
| 2009 | 286.6 Million INR | -19.78% |
| 2008 | 357.25 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 2.29 Billion INR | 73.82% |
| 2023 Q4 | 2.29 Billion INR | 0.0% |
| 2023 Q2 | 1.32 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 1.32 Billion INR | 94.51% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 735.21 Million INR | 0.0% |
| 2022 Q4 | 1.32 Billion INR | 0.0% |
| 2021 Q2 | 646.9 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 680.26 Million INR | 15.49% |
| 2021 Q4 | 680.26 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 589.01 Million INR | 3.44% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 593.28 Million INR | 0.0% |
| 2020 Q2 | 578.29 Million INR | 0.0% |
| 2019 Q4 | 569.43 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 549.03 Million INR | 0.0% |
| 2019 FY | 569.43 Million INR | 10.08% |
| 2018 Q2 | 493.64 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 517.3 Million INR | 2.51% |
| 2018 Q4 | 517.3 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2017 Q4 | 504.65 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 487.03 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 504.65 Million INR | 2.55% |
| 2016 FY | 492.11 Million INR | 17.77% |
| 2016 Q2 | 457.34 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q4 | 492.19 Million INR | 0.0% |
| 2015 FY | 417.86 Million INR | 6.59% |
| 2015 Q4 | 417.86 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 416.9 Million INR | 0.0% |
| 2014 Q2 | 400.99 Million INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 392.04 Million INR | -0.97% |
| 2014 Q4 | 392.04 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q2 | 391.3 Million INR | 0.0% |
| 2013 Q4 | 395.89 Million INR | 0.0% |
| 2013 FY | 395.89 Million INR | 8.92% |
| 2012 Q4 | 363.47 Million INR | 0.0% |
| 2012 FY | 363.47 Million INR | 5.74% |
| 2011 FY | 343.76 Million INR | 21.65% |
| 2011 Q4 | 339.23 Million INR | 0.0% |
| 2010 Q4 | 282.59 Million INR | 0.0% |
| 2010 FY | 282.59 Million INR | -1.4% |
| 2009 FY | 286.6 Million INR | -19.78% |
| 2008 Q4 | 357.25 Million INR | 0.0% |
| 2008 FY | 357.25 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| ANG Lifesciences India Limited | 2.42 Billion INR | 5.136% |
| Bacil Pharma Limited | 13.26 Million INR | -17243.021% |
| BDH Industries Limited | 934.11 Million INR | -146.208% |
| Beryl Drugs Limited | 174.86 Million INR | -1215.189% |
| Cian Healthcare Limited | 1.61 Billion INR | -42.693% |
| Chemo Pharma Laboratories Limited | 130.15 Million INR | -1667.055% |
| Deccan Health Care Limited | 1.08 Billion INR | -112.855% |
| DECIPHER LABS LIMITED | 336.33 Million INR | -583.808% |
| Add-Shop E-Retail Limited | 1.25 Billion INR | -82.595% |
| Concord Drugs Limited | 588.06 Million INR | -291.09% |
| Gujarat Terce Laboratories Limited | 232.73 Million INR | -888.187% |
| Gujarat Themis Biosyn Limited | 2.21 Billion INR | -4.013% |
| Hindustan Bio Sciences Limited | 33.74 Million INR | -6715.807% |
| Ishita Drugs and Industries Limited | 108.08 Million INR | -2027.784% |
| Jenburkt Pharmaceuticals Limited | 1.65 Billion INR | -39.301% |
| KIMIA BIOSCIENCES LIMITED | 999.66 Million INR | -130.063% |
| Kwality Pharmaceuticals Limited | 3.94 Billion INR | 41.659% |
| Makers Laboratories Limited | 1.61 Billion INR | -42.622% |
| Medi-Caps Limited | 1.27 Billion INR | -80.686% |
| MedPlus Health Services Limited | 30.04 Billion INR | 92.346% |
| Panchsheel Organics Limited | 1.59 Billion INR | -44.595% |
| Parmax Pharma Limited | 176.12 Million INR | -1205.8% |
| Parnax Lab Limited | 1.88 Billion INR | -21.837% |
| Patidar Buildcon Limited | 94.27 Million INR | -2339.495% |
| Phaarmasia Limited | 314.47 Million INR | -631.326% |
| PRAVEG LIMITED | 3.64 Billion INR | 36.919% |
| Sunil Healthcare Limited | 1.58 Billion INR | -45.102% |
| Syschem (India) Limited | 1.64 Billion INR | -40.211% |
| Sanjivani Paranteral Limited. | 434.05 Million INR | -429.856% |
| Sastasundar Ventures Limited | 11.49 Billion INR | 79.994% |
| SHAMROCK INDUSTRIAL CO.LTD. | 17.6 Million INR | -12966.633% |
| Smruthi Organics Limited | 1.18 Billion INR | -94.589% |
| Source Natural Foods and Herbal Supplements Limited | 236.5 Million INR | -872.427% |
| SUDARSHAN PHARMA INDUSTRIES LI | 2.83 Billion INR | 18.769% |
| Trident Lifeline Limited | 870.76 Million INR | -164.12% |
| Transchem Limited | 763.18 Million INR | -201.352% |
| Trinity League India Limited | 32.38 Million INR | -7001.396% |
| Tyche Industries Limited | 1.36 Billion INR | -67.996% |
| Vikram Thermo (India) Limited | 1.42 Billion INR | -61.196% |
| Vista Pharmaceuticals Limited | 579.79 Million INR | -296.671% |
| Vivanza Biosciences Limited | 195.01 Million INR | -1079.33% |
| Zenith Healthcare Limited | 97.41 Million INR | -2260.935% |
| Zenlabs Ethica Limited | 402.58 Million INR | -471.274% |
| Mercury Laboratories Limited | 679.57 Million INR | -238.426% |
| SHELTER PHARMA LIMITED | 379.14 Million INR | -506.586% |
| Vasundhara Rasayans Limited | 373.03 Million INR | -516.534% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1.88 Billion INR | -21.913% |
| Roopa Industries Limited | 647.82 Million INR | -255.014% |
| PANJON LTD. | 173.91 Million INR | -1222.426% |
| Pharmaids Pharmaceuticals Limited | 913.4 Million INR | -151.789% |
| TIAAN CONSUMER LIMITED | 95.12 Million INR | -2317.747% |
| Anuh Pharma Limited | 4.45 Billion INR | 48.397% |
| Crestchem Limited | 71.44 Million INR | -3119.196% |
| Emmessar Biotech & Nutrition Limited | 87.42 Million INR | -2530.544% |
| Sandu Pharmaceuticals Limited | 524.14 Million INR | -338.779% |
| Fredun Pharmaceuticals Limited | 3.07 Billion INR | 25.232% |
| Trimurthi Limited | 73.64 Million INR | -3022.726% |
| Shukra Pharmaceuticals Limited | 778.37 Million INR | -195.471% |
| Norris Medicines Limited | 141.87 Million INR | -1521.067% |
| Veerhealth Care Limited | 281.16 Million INR | -717.966% |
| Lactose (India) Limited | 1 Billion INR | -128.299% |
| OXYGENTA PHARMACEUTICAL LIMITE | 631.92 Million INR | -263.947% |
| Ambalal Sarabhai Enterprises Limited | 2.5 Billion INR | 8.09% |
| Denis Chem Lab Limited | 1.09 Billion INR | -110.323% |
| Colinz Laboratories Limited | 113.59 Million INR | -1924.63% |
| Godavari Drugs Limited | 1.34 Billion INR | -70.673% |
| Zenotech Laboratories Limited | 1.06 Billion INR | -116.546% |
| Shree Ganesh Remedies Limited | 1.7 Billion INR | -34.546% |
| Bharat Parenterals Limited | 5.03 Billion INR | 54.352% |
| Coral Laboratories Limited | 2.05 Billion INR | -11.817% |
| Evoq Remedies Limited | 368.61 Million INR | -523.927% |
| Kerala Ayurveda Limited | 1.4 Billion INR | -63.23% |
| KOBO BIOTECH LIMITED | 713.93 Million INR | -222.138% |
| Natural Capsules Limited | 3.76 Billion INR | 38.919% |
| Auro Laboratories Limited | 852.67 Million INR | -169.721% |